Anatomy of Mdm2 and Mdm4 in evolution
Open Access
- 1 February 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 9 (1) , 3-15
Abstract
Mouse double minute (Mdm) genes span an evolutionary timeframe from the ancient eukaryotic placozoa Trichoplax adhaerens to Homo sapiens, implying a significant and possibly conserved cellular role throughout history. Maintenance of DNA integrity and response to DNA damage involve many key regulatory pathways, including precise control over the tumour suppressor protein p53. In most vertebrates, degradation of p53 through proteasomal targeting is primarily mediated by heterodimers of Mdm2 and the Mdm2-related protein Mdm4 (also known as MdmX). Both Mdm2 and Mdm4 have p53-binding regions, acidic domains, zinc fingers, and C-terminal RING domains that are conserved throughout evolution. Vertebrates typically have both Mdm2 and Mdm4 genes, while analyses of sequenced genomes of invertebrate species have identified single Mdm genes, suggesting that a duplication event occurred prior to emergence of jawless vertebrates about 550–440 million years ago. The functional relationship between Mdm and p53 in T. adhaerens, an organism that has existed for 1 billion years, implies that these two proteins have evolved together to maintain a conserved and regulated function.Keywords
Funding Information
- Agency for Science, Technology and Research
This publication has 127 references indexed in Scilit:
- The 5S RNP Couples p53 Homeostasis to Ribosome Biogenesis and Nucleolar StressCell Reports, 2013
- The evolution of MDM2 family genesGene, 2011
- Reciprocal influence of the p53 and the hypoxic pathwaysCell Death & Disease, 2011
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor DevelopmentCancer Cell, 2010
- Diversity and evolution of chromatin proteins encoded by DNA virusesBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- MDM2 and MDM4: p53 regulators as targets in anticancer therapyThe International Journal of Biochemistry & Cell Biology, 2007
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Effective targeted gene ‘knockdown’ in zebrafishNature Genetics, 2000
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997